tirzepatide weight loss fort myers Injections for Medical in Webster TX She didn't just lose 45

The following points detail the effectiveness of tirzepatide in clinical settings: Weight loss outcomes : Tirzepatide has shown to be superior to semaglutide, with patients losing an additional 12 pounds on average at the highest doses Clinical trials reveal that individuals without diabetes using tirzepatide experienced an average weight loss of 18%, with some losing as much as 21% of their body weight on a 15 mg weekly dose For people with diabetes, the average weight loss was around 12% when using tirzepatide A1C reduction and glucose control : In the SURPASS trials, tirzepatide demonstrated a more significant A1C reduction compared to semaglutide and placebo, with reductions of up to 2.1% from baseline levels The trials also noted substantial weight loss, with patients losing up to 12.9 kg (SURPASS-1) and 12.4 kg (SURPASS-2) Sustained efficacy : The SURMOUNT-4 study highlighted that adults using tirzepatide for weight management sustained an average weight loss of 26.0% over 88 weeks These findings underscore tirzepatides potential in providing a dual approach to treating type 2 diabetes and aiding in weight loss, attributed to its unique mechanism that targets both GLP-1 and GIP receptors

However, access to these drugs remains inconsistent across Canada, largely due to differences in coverage across public health plans, private insurance, and employer-sponsored group benefits

Most studies are observational, and long-term data on drug-induced NAION risk with GLP-1 use is still emerging

Make a big batch and enjoy it throughout the week

No nausea, and my research showed complete appetite control